Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Intrexon Corp (NYSE:XON)

23.65
Delayed Data
As of 4:02pm ET
 +0.65 / +2.83%
Today’s Change
18.41
Today|||52-Week Range
32.58
-1.73%
Year-to-Date

Today’s Trading

Previous close23.00
Today’s open22.98
Day’s range22.97 - 23.74
Volume605,763
Average volume (3 months)1,018,997
Market cap$2.8B
Dividend yield--
Data as of 4:02pm ET, 07/20/2017

Growth & Valuation

Earnings growth (last year)-107.89%
Earnings growth (this year)+42.09%
Earnings growth (next 5 years)-78.25%
Revenue growth (last year)+9.98%
P/E ratioNM
Price/Sales15.02
Price/Book4.87

Competitors

 Today’s
change
Today’s
% change
AVXSAveXis Inc-0.04-0.05%
JUNOJuno Therapeutics In...+0.81+2.87%
NKTRNektar Therapeutics+0.51+2.35%
BPMCBlueprint Medicines ...+1.27+2.38%
Data as of 4:00pm ET, 07/20/2017

Financials

Next reporting dateAugust 16, 2017
EPS forecast (this quarter)-$0.22
Annual revenue (last year)$190.9M
Annual profit (last year)-$186.6M
Net profit margin-97.74%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Randal J. Kirk
Chief Operating Officer
Andrew J. Last
Corporate headquarters
Germantown, Maryland

Forecasts